1. Home
  2. INM vs LANC Comparison

INM vs LANC Comparison

Compare INM & LANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INM
  • LANC
  • Stock Information
  • Founded
  • INM 1981
  • LANC 1961
  • Country
  • INM Canada
  • LANC United States
  • Employees
  • INM N/A
  • LANC N/A
  • Industry
  • INM Biotechnology: Pharmaceutical Preparations
  • LANC Packaged Foods
  • Sector
  • INM Health Care
  • LANC Consumer Staples
  • Exchange
  • INM Nasdaq
  • LANC Nasdaq
  • Market Cap
  • INM 3.2M
  • LANC N/A
  • IPO Year
  • INM N/A
  • LANC N/A
  • Fundamental
  • Price
  • INM $2.37
  • LANC $167.02
  • Analyst Decision
  • INM
  • LANC Buy
  • Analyst Count
  • INM 0
  • LANC 4
  • Target Price
  • INM N/A
  • LANC $209.67
  • AVG Volume (30 Days)
  • INM 46.6K
  • LANC 222.8K
  • Earning Date
  • INM 05-13-2025
  • LANC 04-30-2025
  • Dividend Yield
  • INM N/A
  • LANC 2.30%
  • EPS Growth
  • INM N/A
  • LANC 27.36
  • EPS
  • INM N/A
  • LANC 6.15
  • Revenue
  • INM $4,832,013.00
  • LANC $1,886,520,000.00
  • Revenue This Year
  • INM N/A
  • LANC $5.03
  • Revenue Next Year
  • INM N/A
  • LANC $3.31
  • P/E Ratio
  • INM N/A
  • LANC $26.87
  • Revenue Growth
  • INM N/A
  • LANC 0.69
  • 52 Week Low
  • INM $1.72
  • LANC $156.14
  • 52 Week High
  • INM $15.70
  • LANC $202.63
  • Technical
  • Relative Strength Index (RSI)
  • INM 34.09
  • LANC 37.40
  • Support Level
  • INM $2.70
  • LANC $158.84
  • Resistance Level
  • INM $3.20
  • LANC $166.20
  • Average True Range (ATR)
  • INM 0.23
  • LANC 4.62
  • MACD
  • INM -0.05
  • LANC -2.17
  • Stochastic Oscillator
  • INM 5.26
  • LANC 22.20

About INM InMed Pharmaceuticals Inc.

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

Share on Social Networks: